Track the 한화생명 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Banks sector, 한화생명 has recorded 216 insider filings. Market capitalisation: €4,433.2bn. The latest transaction was filed on 13 July 2026 (Purchase). Among the most active insiders: 김국진. All data is openly available.
216
Insider Decl.
n/a
Thresholds
€8,932
81 ops.
Buy Volume
n/a
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 한화생명 Buy (bullish), based on 13 analysts. Average price target: ₩5,315.
22Σ signal
Buys €8,932n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,970 of 29,228 companies
71.0
score / 100
Value
95
Quality
47
FCF yld·
Earn yld17%
EV/EBITDA4.1x
ROE7.9%
Gross mgn·
Net mgn4.4%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.